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AbstrACt: background: The reduced expression of CD10 may be related to unfavorable prognosis of patients with colorectal 
carcinoma. The authors analyzed the tissue immunostaining of CD10 protein in colorectal carcinoma and its relationship to clini-
copathologic features. Method: In 130 patients submitted to colorectal carcinoma surgery, a tissue microarray block was obtained 
from the tumor and adjacent non-neoplastic mucosa and submitted to immunohistochemistry with monoclonal antibody CD10. 
The immunostaining was evaluated by semi-quantitative method, with stained cell count in percentage. The results were related 
to the location, anatomopathological features, presence of lymph node and hepatic metastases and TNM staging of the colorectal 
neoplasm. The statistical analysis was performed with the Mann-Whitney, Kruskal-Wallis and Fisher exact tests. results: The ex-
pression of CD10 marker was higher in colorectal tumor tissue than in adjacent non-neoplastic mucosa (p<0.0001) and was higher 
than in exophytic lesions (p=0.04). The expression of CD10 protein was not associated with other clinical and pathological aspects 
of colorectal neoplasm. Conclusions: The expression of CD10 protein was more intense in tumor tissue of colorectal carcinoma than 
in adjacent non-neoplastic mucosa and was related to the exophytic appearance of the tumor.
Keywords: neoplasm antigens; colorectal neoplasms; prognosis; neoplasm metastasis; CD10 antigens. 
resuMO: Introdução: A expressão reduzida de CD10 pode estar relacionada com prognóstico desfavorável de doentes com carcinoma 
colorretal. Analisou-se a imunoexpressão tecidual da proteína CD10 no carcinoma colorretal e sua relação com os aspectos clinicopato-
lógicos. Método: Em 130 doentes operados por carcinoma colorretal, um bloco de tissue microarray foi obtido do tecido neoplásico e da 
mucosa não neoplásica adjacente e submetido ao estudo imuno-histoquímico com anticorpo monoclonal CD10. Avaliou-se a imunoexpres-
são por método semiquantitativo, com contagem do percentual de células coradas. Os resultados foram relacionados com a localização, 
aspectos anatomopatológicos, presença de metástases linfonodais e hepáticas e estadiamento TNM da neoplasia. O estudo estatístico foi 
realizado com os testes de Mann-Whitney, Kruskal-Wallis e exato de Fisher. resultados: A expressão do marcador CD10 foi maior no te-
cido do carcinoma colorretal do que na mucosa não neoplásica adjacente (p<0,0001) e foi maior nas lesões exofíticas (p=0,04). A expressão 
da proteína CD10 não apresentou relação com os demais aspetos clínicos e patológicos da neoplasia colorretal. Conclusões: A expressão 
da proteína CD10 foi mais intensa no tecido neoplásico do carcinoma colorretal do que na mucosa não neoplásica adjacente e relacionou-se 
com o aspecto exofítico do tumor. 
Palavras-chave: antígenos de neoplasia; neoplasias colorretais; prognóstico; metástase neoplásica; antígenos CD10.
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INtrODuCtION
The CD10 tissue marker was originally described 
in neoplastic cells of patients with leukemia and was 
used as a marker in acute lymphblastic leukemia. Lat-
er, it was identified in liver cell, breast and neoplasm 
cell of the large bowel1,2. It is a 100 kDa glycoprotein, 
with strong expression in the brush border of the intes-
tinal epithelium, germinal centers of lymph node folli-
cles and liver microvilli. Studies1-3 have associated this 
marker with the appearance of liver metastasis, venous 
invasion and progression of these tumors to more ad-
vanced stages in patients with colorectal neoplasm.
Considering the high incidence of colorectal neo-
plasm worldwide and the difficult prognosis of patients 
with this disease, specially in stages II and III of the 
TNM classification, we studied the expression of CD10 
tumor marker and its relations with the anatomopatho-
logical aspects of the neoplasm, the presence of lymph 
node and liver metastases and the survival of patients 
submitted to colorectal carcinoma surgery.
MetHOD
This study was approved by the Research Ethics 
Committee of the Universidade Federal de São Paulo 
(UNIFESP) and registered under 1958/07.
The inclusion criterion of this study was: adult 
patient with colorectal carcinoma confirmed through 
an anatomopathological exam. The exclusion criteria 
were: presence of hereditary colorectal cancer, Crohn’s 
disease, ulcerative rectocolitis, colorectal metachronic 
cancer or cancer of another origin and another previ-
ously treated neoplasm. 
The study analyzed 130 patients with colorec-
tal carcinoma, mean age of 64.2±9.6 years (29 to 90 
years old), submitted to curative or palliative surgery, 
between October 2001 and March 2005 at the Hospi-
tal São Paulo, by the Coloproctology Group of Surgical 
Gastroenterology of the Department of Surgery of the 
Universidade Federal de São Paulo – Escola Paulista de 
Medicina (UNIFESP – EPM). There were 65 male pa-
tients (50%) and 65 female patients (50%). Eighty-two 
of them (63.1%) had been submitted to curative inter-
vention and 48 (36.9%) to palliative intervention.
The parameters analyzed were: macroscopic (lo-
cation and aspect) and microscopic characteristics (de-
gree of histological differentiation and lymphatic, vas-
cular and neural invasion) of the lesion, clinical staging, 
according to the TNM classification developed by the 
Union for International Cancer Control (UICC), pres-
ence of liver metastases and in other locations and tis-
sue immunoexpression of CD10 in the colorectal carci-
noma tissue, evaluating the intensity of immunostaining 
versus the percentage of immunostained cells.
For the production of a tissue microarray (TMA) 
block, all cases of colorectal carcinoma were evalu-
ated by two pathologists through histological sec-
tions with hematoxylin-eosin (HE) stain, regarding 
the histological degree, diagnosis confirmation and 
selection of core removal sites for the TMA exam. 
With a BeecherTM device (Beecher Instruments, Silver 
Spring, MD, USA), TMA blocks were produced, us-
ing the standard technique4. For the adhesion of the 
TMA block sections to the blades, a system of adhe-
sive tapes was used (Instrumedics Inc., Hackensak, 
NJ, USA). The samples were cut with 4 µm thickness, 
and a small roll was used to pressure the section to the 
tape. Then, the tape with adhered histological section 
was placed on the resin-coated blade and pressed with 
the roll for better adherence. After that, the blades with 
histological sections adhered to the tapes were placed 
under ultraviolet (UV) light for 20 min. The blades 
were dried and the adhesive tapes were removed. The 
blades were then sent for immunohistochemical anal-
ysis. The technique of streptavidin-biotin-peroxidase 
with monoclonal antibody CD10 (56C6 clone, Neo-
markers, USA) was used, applying the 1:40 dilution.
The evaluation of protein immunoexpression 
was performed in the tumor tissue and non-neoplastic 
mucosa taken from the surgical margins adjacent to 
the tumor. Brown color in the cytoplasmic or mem-
branous area of the cell was considered as positive 
immunoexpression for the studied antibodies. The 
positive control were sections of the germinal cen-
ter area in normal tonsil for anti-CD10 antibody. On 
blades used as negative control, the primary antibody 
of the reaction was subtracted. The immunoexpres-
sion evaluation was performed by two experienced 
pathologists and in isolated form. Divergences were 
submitted to a joint analysis.
The sections were analyzed using a blade scanner 
(Scan Scope CS System, Aperio, United Kingdom), a 
blade scanning system that produces high-resolution 
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images. The percentage of cells with positive reac-
tion was analyzed in high enlargement field (400x). 
The images were captured using a camera (Samsung, 
South Korea) and WinTV32 connected to a micro-
scope (Bx40, Olympus, Japan). The positive and neg-
ative expressions were identified in the neoplastic tis-
sue and the normal mucosa tissue.
The criteria used in the evaluation of CD10 pro-
teins were those established by Ogino et al.5. The neg-
ative samples were those with less than 10% of stained 
cells and the positive samples were those with more 
than 10% of stained cells6. The percentage of stained 
cells was used as indicator of marker expression de-
gree. Score 0 indicated less than 10% of stained cells; 
score 1 indicated 11 to 25% of stained cells; score 2 
indicated 26 to 50% of stained cells; score 3 indicated 
more than 50% of stained cells. The cells with doubt-
ful stain and those considered as morphologically 
non-neoplastic cells were excluded from the immuno-
expression evaluation of markers.
Data related to quantitative variables were present-
ed as mean values. The categorical variables were ana-
lyzed using the Mann-Whitney test and the correlation 
between them was performed using the Spearman test. 
The analysis of variance in the samples from the three 
groups or more was performed using the Kruskal-Wallis 
test and the dichotomous variables were analyzed using 
Fisher’s exact test. The significance level adopted was 
lower than 0.05, or 5%. The statistical program used 
was Prism 4.0 (GraphPad Software Inc., USA). 
resuLts
The lesions were in the colon in 78 (60%) cases 
in the rectum in 52 (40%) patients. The expression of 
CD10 did not show any significant difference (p=0.79) 
in relation to its location in the colon or rectum.
The mean score of CD10 expression in the tumor tis-
sue (Figure 1) was 1.2 and in the non-neoplastic mucosa 
was 0.1, and this difference was significant (p<0.0001).
Figure 1. Colorectal carcinoma with cytoplasmic and membranous positive expression for CD10 marker (immunohistochemical analysis). 
(A) Intense (100x); (B) Intense (400x); (C) Mild (200x) and (D) Intense, with brush border pattern (200x ). 
A
C D
B
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Degree of differentiation n %
Well differentiated 52 40.0
Moderately differentiated 70 53.8
Poorly differentiated 8 6.2
Total 130 100.0
Table 2. Distribution of patients according to the degree 
of cell differentiation of the colorectal carcinoma.
Fisher’s exact test: p=0.4 (N.S.).
n: number of patients; N.S.: Non-Significant.
Invasion No Yes p-value
Lymphatic 52 (40.0%) 78 (60.0%) 0.4 (N.S.)
Vascular 103 (79.2%) 27 (20.8%) 0.5 (N.S.)
Perineural 92 (70.8%) 38 (29.2%) 0.2 (N.S.)
Table 3. Distribution of patients according to 
lymphatic, vascular and perineural invasion of the 
colorectal carcinoma.
Fisher’s exact test.
N: number of patients; N.S.: Non-Significant.
Clinical stage n %
I 9 6.9 
II 44 33.8
III 45 34.6
IV 32 24.6
Total 130 100.0
Table 4. Distribution of patients according to the 
clinical stages of the TNM classification for colorectal 
carcinoma.
Fisher’s exact test: p=0.09 (N.S.).
n: number of patients; N.S.: Non-Significant.
Metastasis n %
Absent 79 60.8
Other sites, except liver 27 20.8
Only liver 19 14.6
Liver and other sites 5 3.8
Total 130 100.0
Table 5. Distribution of patients according to the 
occurrence of metastasis in relation to the preoperative 
and/or postoperative distance.
Fisher’s exact test: p=0.3 (N.S.).
n: number of patients; N.S.: Non-Significant.
In 85 (65.6%) cases, the macroscopic aspect 
was exophytic, in 17 (13.1%) cases, it was non-exo-
phytic and 28 (21.5%) cases did not present any ref-
erence to the macroscopic aspect of the neoplasm. 
The CD10 immunoexpression was significantly 
higher (p=0.04) in carcinomas with exophytic mac-
roscopic than in those with non-exophytic macro-
scopic aspect (Table 1).
The distribution of cell differentiation de-
gree of tumors and the expression of CD10 tumor 
marker did not show any significant difference 
(p=0.48) (Table 2).
Lymph node infiltration was observed in 55 
(42.3%) patients, 46 (35.4%) patients had free 
lymph nodes and 29 (22.3%) patients submitted 
to palliative surgery had no lymph nodes. No sig-
nificant difference (p=0.3) was observed between 
the expression of CD10 and the presence of lymph 
node infiltration.
Regarding the presence of vascular, lymphatic 
and perineural invasion, the expression of CD10 did 
not show any significant difference in relation to lym-
phatic invasion (p=0.4), vascular invasion (p=0.5) and 
perineural invasion (p=0.2) (Table 3).
CD10
Macroscopic Aspect (n=101)  p=0.04*
exophytic (n) Non-exophytic (n)
Positive 10 (58.82%) 26 (38.29%)
Negative 7 (41.17%) 58 (61.70%)
Fisher’s exact test
n: number of patients; *: Significant.
Table 1. Immunoexpression of CD10 marker according 
to the exophytic or non-exophytic macroscopic aspect 
of colorectal carcinoma.
The TNM classification of colorectal neoplasms 
did not show any significant difference (p=0.09) in re-
lation to the expression of CD10 (Table 4).
Regarding the presence of liver metastases or 
the preoperative and/or postoperative distance, no 
significant difference (p=0.3) was observed in re-
lation to the expression of CD10 in the colorectal 
tissue (Table 5).
Tissue expression of CD10 protein in colorectal carcinoma: correlation with the 
anatomopathological features of the tumor and with lymph node and liver metastasesx
Levindo Alves de Oliveira et al.
38
J Coloproctol
January/March, 2012
Vol. 32
Nº 1
DIsCussION
The colorectal carcinoma tissue analysis used the 
TM, which employs a small sample of the tumor tis-
sue. The TMA validation for colorectal tumor studies 
was obtained from a study of cytokeratin expression in 
colorectal carcinoma7. This method enables the utili-
zation of reduced antibodies and tissues and antibody 
immunoexpression homogenization, as the immuno-
histochemical reaction is performed at the same time 
and on the same blade in all cases8. 
The studied used the blade analysis and scan-
ning system, where the cell structure was analyzed 
without the help of microscopes. In this system, the 
computer acts as a “robotized microscope”. The im-
age moves in high definition on the same blade and, 
within a few minutes, it is homogeneously scanned. 
The statistical analysis of the sample showed a direct 
relation between the quantity of stained cells and the 
stain intensity for the CD10 marker. Considering this 
finding, the percentage of stained cells was used as the 
indicator of marker expression degree, just as other 
authors have done9-12. 
The expression of CD10 marker in this study 
was significantly higher in the neoplastic tissue than 
in normal mucosa. This finding suggests the partici-
pation of this protein in the sequence of events for 
neoplastic alterations. The CD10 maker is a mem-
brane-associated peptidase related to peptide cleav-
age. This event is believed to be related to neoplas-
tic progression2. Studies have identified a difference 
in marker expression in tumors and non-neoplastic 
colorectal mucosa adjacent to the tumor1,13,14.  Oga-
wa et al.15 studied the expression of CD10 in tumor 
tissue of colorectal carcinoma and did not find any 
expression of this marker in samples of non-neo-
plastic mucosa adjacent to the tumor. 
The literature controversial regarding the expres-
sion of this marker and the presence of liver metasta-
sis11. Fujita et al.16 evaluated the expression of CD10 
and did not find any relation between the expression of 
CD10 and the occurrence of liver metastasis. On the 
other hand, Fujimoto et al.10 identified a strong expres-
sion of CD10 in patients with higher incidence of me-
tastases, which was also observed by Yao et al.17 and 
Ohji et al.2. This study did not identify any significant 
relation of the CD10 expression to the occurrence of 
liver metastases, which can be explained by the fact 
that this study only recruited patients with synchronic 
liver metastases.
The expression of CD10 in this study was simi-
lar in the various degrees of colorectal carcinoma dif-
ferentiation. Sato et al.1 identified a higher expression 
of CD10 in colorectal carcinomas well or moderately 
differentiated and a lower expression in poorly differ-
entiated neoplasms. Fujimoto et al.10 observed that the 
expression of CD10 was higher in well differentiated 
tumors when compared to the others. Oshima et al.18 
did not observe any difference in the expression re-
garding the histological differentiation.
The expression of this marker in this study was 
similar in tumors that presented or not angiolymphat-
ic and/or perineural invasion. Fujimoto et al.10 iden-
tified a significant association with angiolymphatic 
and/or perineural invasion, but Fujita et al.16 did not 
observe any significant relation. Yao et al.17 identi-
fied greater venous invasion in tumors with positive 
expression of CD10. 
In this sample, the expression of CD10 did not 
show any significant difference in terms of clinical 
stage of the colorectal neoplasm, which was also ob-
served by Fujita et al.16.
A tendency of exophytic tumors with higher ex-
pression of CD10 than in non-exophytic tumors, which 
indicates that neoplasms with CD10 positive lines tend 
to be significantly more exophytic than CD10 positive 
lines. Ogawa et al.15 analyzed the expression of CD10 
in the cell stroma in the several stages of carcinogen-
esis and observed an expression of this marker sig-
nificantly more positive in protruding lesions than in 
superficial lesions. These authors also observed that 
the expression of this marker was higher in more vo-
luminous tumors.
This study did not observe any significant differ-
ence in the expression of CD10 markers in terms car-
cinoma either in the rectum or colon, just as other au-
thors have also observed16,17,19. The analysis of CD10 
expression did not present any relation to the occur-
rence of lymph node metastasis, just as observed by 
Yao et al.17. Fujita et al.16 analyzed the expression of 
CD10 through polymerase chain reaction (PCR) and 
identified a higher expression of this market in N1 
and N2 tumors than in N0 tumors, but this difference 
was not significant.
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CONCLusIONs
The expression of CD10 protein was higher in 
the neoplastic tissue of colorectal carcinoma than 
in the adjacent non-neoplastic mucosa and pre-
sented association with the exophytic aspect of tu-
mor. The immunoexpression of CD10 protein did 
not show any relation to the neoplasm location in 
the colon or rectum, presence of lymph node or 
liver metastases, or in any other site, angiolym-
phatic and/or perineural invasion, degree of cell 
differentiation and TNM staging.
